Tanaka Keigo, Sakakima Harutoshi, Hida Kazutoshi, Hatanaka Kanako, Ijiri Kosei
Yunomoto Memorial Hospital, Kagoshima, Japan.
School of Health Sciences, Faculty of Medicine, Kagoshima University, Kagoshima, Japan.
Case Rep Orthop. 2017;2017:3284131. doi: 10.1155/2017/3284131. Epub 2017 Sep 12.
Chordoma arising from the cervical spine is rare and the traditional long-term prognosis is typically poor. Total en bloc spondylectomy with a wide margin is generally accepted to be the most appropriate management for thoracic and lumbar malignant tumors. However, this method is still challenging for the cervical spine because of the proximity of the tumor to the vertebral arteries and neural elements. Here, we report a 73-year-old man with a C5 vertebral chordoma treated with total piecemeal spondylectomy. Histological examination revealed pathognomonic physaliphorous cells with mucus-filled cytoplasm in the tumor, and the ratio of Ki-67-positive cells within the tumor was high (19.0%), showing active proliferation rate. Local recurrences were found at 9 months, 4 years and 2 months, and 6 years after the initial surgery. All the recurrences were encapsulated and isolated and treated with an additional en bloc resection successfully at each stage. Eight years after the initial total piecemeal spondylectomy, the patient maintained his intact neurological status without local recurrence or metastasis. The prognosis of cervical chordoma depends on the patient's age, surgical procedures, and histological features. In this report, we present that piecemeal spondylectomy is an alternative management for aged patients with cervical chordoma, even for those with high MIB-1 index.
起源于颈椎的脊索瘤较为罕见,传统的长期预后通常较差。整块全脊椎切除术加广泛切缘一般被认为是胸腰椎恶性肿瘤最合适的治疗方法。然而,由于肿瘤靠近椎动脉和神经结构,这种方法在颈椎手术中仍具有挑战性。在此,我们报告一例73岁男性C5椎体脊索瘤患者,接受了逐块全脊椎切除术。组织学检查显示肿瘤中有特征性的大空泡细胞,其胞质内充满黏液,肿瘤内Ki-67阳性细胞比例较高(19.0%),提示增殖活跃。在初次手术后9个月、4年2个月和6年发现局部复发。所有复发病灶均有包膜且孤立,每次均成功进行了额外的整块切除治疗。初次逐块全脊椎切除术后8年,患者神经功能完整,无局部复发或转移。颈椎脊索瘤的预后取决于患者年龄、手术方式和组织学特征。在本报告中,我们提出逐块全脊椎切除术是老年颈椎脊索瘤患者的一种替代治疗方法,即使是那些MIB-1指数较高的患者。